Herpes simplex virus (HSV) exists in two forms—HSV-1 and HSV-2—both capable of causing lifelong infections that remain dormant in the body and periodically reactivate. HSV-1 has historically been associated with oral infections like cold sores and typically settles in the trigeminal ganglia, a nerve cluster near the face. HSV-2, on the other hand, is more commonly linked to genital herpes and tends to establish latency in the sacral ganglia at the base of the spine. Despite these traditional patterns, both viruses are capable of infecting either the oral or genital regions.
Transmission occurs through direct contact with mucous membranes or broken skin and doesn’t always require visible symptoms. This means people can spread the virus unknowingly, which makes understanding its behavior all the more critical.
The way herpes presents in the body is closely tied to where it resides. While HSV-1 more often causes facial and mouth-related symptoms, HSV-2 typically affects the genital area. Recognizing the virus type and the site it affects isn’t just medically useful—it’s essential. It shapes how symptoms are managed, how transmission risks are assessed, and how people communicate with partners about their health.
Complicating matters, however, is the growing overlap between HSV-1 and HSV-2 in both symptom location and infection route. With oral sex increasingly common, HSV-1 has become a leading cause of genital herpes, especially in younger populations. Some people may even carry both types, sometimes in the same region, which can blur the clinical picture and complicate diagnosis.
That’s why this article exists. Our aim is to untangle the confusion between oral and genital herpes, clarify how the different types behave in different parts of the body, and empower you with clear, compassionate information. By understanding the distinctions, you can make more confident decisions about your health, relationships, and long-term care.
HSV-1 vs. HSV-2: A Quick Refresher
Herpes simplex virus comes in two main types: HSV-1 and HSV-2. While they are closely related, they tend to behave differently in the body. HSV-1 has traditionally been associated with oral infections like cold sores, while HSV-2 has more commonly been linked to genital herpes. This pattern stems from differences in how each type interacts with the body’s tissues and how they are typically transmitted.
HSV-1 is usually acquired in childhood through non-sexual contact, such as kissing or shared utensils, and is most often seen as orolabial lesions. HSV-2, in contrast, is typically contracted during adolescence or adulthood through sexual activity and tends to affect the genital region. That said, these lines are no longer as clear-cut as they once were.
Modern sexual practices, particularly oral-genital contact, have blurred the historical boundaries. HSV-1 now accounts for a significant portion of new genital herpes infections, especially in younger populations. Though less efficient at spreading orally, HSV-2 can also cause oral herpes. These cross-site infections are possible because both virus types share similar structures, including glycoproteins that enable them to infect mucous membranes in either region.
Understanding which type of herpes a person has—and where it appears—is important, not only for symptom management but also for anticipating recurrences and assessing transmission risks. Still, the distinctions can be confusing. Misdiagnosis or mistyping may occur, especially when both viruses are present in the same site.
When it comes to prevalence, HSV-1 remains widespread around the world. In the United States, nearly half of people aged 14 to 49 test positive for HSV-1, although this number has slowly declined. HSV-2 is less common overall, affecting about 10 to 20 percent of adults in North America, but prevalence can be much higher in certain groups, such as patients at STI clinics. Increasingly, however, HSV-1 is being identified as the cause of genital herpes cases among younger adults, a shift that reflects changing norms around sexual behavior.
Transmission Pathways: What’s the Difference?
Herpes simplex virus spreads through direct contact, but the specifics differ depending on the type and site of infection. Understanding these routes of transmission helps clarify how people become infected and why prevention can be challenging.
Oral Herpes (Typically HSV-1)
HSV-1 is most commonly passed through saliva and close personal interactions. Kissing, sharing eating utensils, lip balm, or even towels can be enough to transmit the virus, especially when someone has an active outbreak. Many people acquire HSV-1 in early childhood through contact with family members, often without knowing it.
Though HSV-1 is most recognized for causing cold sores around the mouth, it’s also capable of being transmitted to the genital area through oral sex. This has led to a noticeable increase in genital herpes cases caused by HSV-1, particularly among younger people who may not view oral sex as risky.
Genital Herpes (Typically HSV-2)
HSV-2 is primarily transmitted through sexual contact—whether that involves genital, anal, or oral sex. The virus spreads most efficiently during genital-to-genital contact, largely because of the vulnerability of mucous membranes and the friction involved, which can create tiny skin abrasions.
Even without visible sores, HSV-2 can still be passed on. This is due to asymptomatic shedding, where the virus is present on the skin without any outward signs. As a result, someone may transmit the virus without knowing they have it or during periods when symptoms are not active.
Crossover Possibility
The distinction between oral and genital herpes types is not as firm as once believed. Oral HSV-1 can—and increasingly does—cause genital infections when spread through oral-genital sex. In fact, HSV-1 is now a leading cause of primary genital herpes in several populations.
While it’s far less common, HSV-2 can occasionally lead to oral infections, especially in individuals who already have genital HSV-2. These cases are rare but documented. Additionally, nonsexual crossover can happen through autoinoculation, where a person accidentally transfers the virus from one site to another—for instance, from mouth to genitals—often during an active outbreak and in the absence of proper hygiene.
Symptom Location and Appearance
The symptoms of herpes vary depending on where the infection takes hold, but many aspects of the virus’s activity are shared across both oral and genital forms. Understanding these patterns can help people recognize early signs, seek appropriate care, and manage outbreaks more effectively.
Oral Herpes Symptoms
Oral herpes, usually caused by HSV-1, often begins with a tingling or itching sensation around the lips or mouth. This is typically followed by the development of painful blisters or sores, which may appear on the lips, gums, nose, or the surrounding skin. In children or those with weakened immune systems, these lesions can also extend to the roof of the mouth or the gums, making eating and drinking uncomfortable.
Initial infections may be more severe and can come with additional symptoms such as a sore throat, fever, swollen glands, and difficulty swallowing. These more systemic signs are especially common during a person’s first outbreak.
Genital Herpes Symptoms
Genital herpes, often linked to HSV-2, typically causes clusters of painful blisters or open sores around the genitals, anus, buttocks, or inner thighs. The first outbreak tends to be the most intense and may include flu-like symptoms—fever, headaches, and swollen lymph nodes. Some people, particularly women, might also experience painful urination or unusual discharge during a primary infection.
Even after these symptoms subside, the virus remains in the body and may reactivate periodically, though future outbreaks are often less severe.
Similarities in Prodrome and Healing Stages
Regardless of whether the infection is oral or genital, many people experience a prodrome: a warning phase marked by tingling, burning, or itching at the site where sores are about to appear. This can serve as a valuable early signal of an oncoming outbreak.
The sores themselves tend to follow a predictable pattern. Blisters form first, then rupture into shallow ulcers, which scab over and heal within one to two weeks. While the physical discomfort can be distressing, the lesions usually heal without scarring.
Differences in Recurrence and Severity
While both HSV-1 and HSV-2 can cause recurring outbreaks, the frequency and intensity of these episodes often depend on the virus type and the location of infection.
HSV-2 Recurs More Often and More Intensely
Genital infections caused by HSV-2 tend to recur more frequently than those caused by HSV-1. Research shows that individuals with genital HSV-2 experience recurrences at a rate of about one every three weeks, compared to roughly one every two years for genital HSV-1. This difference can be particularly important for long-term symptom management.
The first outbreak of genital HSV-2 is also typically more severe. People often experience systemic symptoms like fever, fatigue, swollen lymph nodes, and extensive sores. In contrast, genital HSV-1 usually presents with milder and less persistent symptoms. For those with compromised immune systems, HSV-2 can cause more frequent and intense reactivations, often due to weakened immune surveillance.
Roughly 90 percent of people with genital HSV-2 will have at least one recurrence within the first year, making it a more persistent presence in daily life compared to HSV-1.
Oral HSV-1 Tends to Fade Over Time
Oral HSV-1 outbreaks, while common in early life, generally become less frequent with age. Many adults who experienced cold sores as children find that outbreaks slow or even stop altogether later in life. This decline is likely due to the immune system’s increasing efficiency at keeping the virus in check.
Among immunocompetent individuals, the likelihood of future outbreaks steadily drops over time, despite the virus remaining latent in the body.
Recurrence Patterns Depend on Both Virus Type and Infection Site
How often outbreaks occur—and how severe they are—also depends on where the virus resides in the body. HSV-2 in the genital region is the most likely to recur, followed by HSV-1 in the oral region. Genital HSV-1 and oral HSV-2 are both less common and less prone to repeated activation.
This pattern is influenced by the virus’s relationship with the nervous system. HSV-1 tends to reactivate more readily from the trigeminal ganglia, which serve the facial area, while HSV-2 reactivates from the sacral ganglia, which serve the lower body. When a virus aligns with its “preferred” site—HSV-1 in the mouth, HSV-2 in the genitals—reactivations are often more efficient, and thus more likely to occur.
Emotional and Social Stigma: Does It Differ?
Herpes can carry emotional weight beyond its physical symptoms, but the experience of stigma often differs depending on whether a person has oral or genital herpes.
Oral Herpes: A Familiar, Less Stigmatized Condition
Oral herpes, most often caused by HSV-1, is widely seen as a common, even mundane, skin condition. Many people first acquire it in childhood through casual, non-sexual contact like kissing or sharing utensils. Because of this early-life prevalence, society generally views oral herpes through a nonjudgmental lens.
Cultural and media portrayals contribute to this normalization. Cold sores are typically discussed without sexual connotation, and public discourse often avoids the kind of language that can stigmatize those with HSV-1. As a result, people with oral herpes rarely face the same emotional or social hurdles seen with genital HSV.
Genital Herpes: Heavier Stigma, More Emotional Strain
By contrast, genital herpes—often linked to HSV-2—remains burdened by stigma. Its association with sexual transmission fuels feelings of shame, fear, and isolation in many who receive a diagnosis. Even though the condition is medically manageable and extremely common, it is frequently misunderstood, with outdated stereotypes still shaping public perceptions.
The emotional toll can be significant. Many people experience depression, anxiety, or lowered self-esteem after learning they have genital herpes. These feelings are often reinforced by societal messages that equate the diagnosis with irresponsibility or moral failure—an association that has no medical basis but deep roots in cultural narratives.
Impact on Disclosure and Relationships
This stigma has real consequences. People diagnosed with genital herpes often delay or avoid disclosing their status to partners, fearing rejection or judgment. It can complicate romantic and sexual relationships, adding stress to communication and intimacy.
In clinical settings, the stigma can be reinforced by a lack of open, affirming sexual health education. Without supportive dialogue, individuals may internalize shame and miss opportunities for connection and care. Even among people already managing other health challenges—such as those living with HIV—a new diagnosis of genital herpes can resurface emotional struggles, though many adjust well with adequate support.
Acknowledging these differences in stigma is essential for fostering empathy and encouraging informed, respectful conversations. Herpes—regardless of type—should never be a source of shame. Reframing it as a manageable health condition, rather than a moral failing, helps reduce the emotional burden and supports better self-image and relationship dynamics.
Risks of Transmission and Asymptomatic Shedding
Herpes simplex virus is often misunderstood in terms of how and when it can spread. One of the most important—and least visible—factors in transmission is asymptomatic shedding, where the virus is present on the skin or mucosa even when no symptoms are showing.
Shedding Can Happen Without Warning
Both HSV-1 and HSV-2 can be transmitted during periods when no blisters or sores are visible. This phenomenon, known as asymptomatic viral shedding, plays a major role in the spread of herpes. In fact, most new infections are thought to occur this way. Shedding can take place from the lips, genitals, or anus, depending on the site of infection, and can happen sporadically, even after long stretches of dormancy.
Because there are often no external signs, individuals may unknowingly transmit the virus to partners, which makes education and awareness crucial to prevention.
HSV-2 Sheds More Frequently Than HSV-1
Not all shedding is equal. HSV-2 is significantly more likely than HSV-1 to shed without symptoms, especially in the genital region. Studies have shown that people with genital HSV-2 may shed the virus on 10 to 20 percent of days, even when they feel fine. Women, in particular, tend to experience longer and more frequent shedding episodes than men, increasing the potential for unintentional transmission.
This difference helps explain why HSV-2 spreads more efficiently than HSV-1 in sexual settings.
Reducing the Risk
Despite these challenges, there are effective strategies to reduce the risk of passing herpes to others:
- Suppressive antiviral therapy, such as daily valacyclovir, can cut the risk of transmission by about half. It also reduces the frequency of both symptomatic outbreaks and asymptomatic shedding.
- Consistent condom use lowers transmission risk by roughly 30 percent, especially during asymptomatic periods. While not foolproof, condoms provide a significant layer of protection.
- Avoiding sex during outbreaks remains one of the most effective ways to prevent transmission, as active lesions are especially contagious.
Understanding how herpes can spread—even when invisible—helps people make informed decisions and practice safer sex without stigma or fear. It’s about managing risk, not eliminating intimacy.
Testing and Diagnosis Nuances
Diagnosing herpes simplex virus isn’t always straightforward. Because symptoms can be mild, mistaken for other conditions, or completely absent, testing methods and clinical judgment must work together to provide clarity.
Blood Tests Can Distinguish HSV-1 and HSV-2 Antibodies
When no active lesions are present, blood tests can detect HSV antibodies, helping to determine whether a person has been exposed to HSV-1, HSV-2, or both. These type-specific tests use glycoprotein G to accurately distinguish between the two strains. They’re especially useful for people with recurrent symptoms but negative swab results or for those whose partners have confirmed herpes.
That said, serologic testing isn’t flawless. False positives can occur, especially for HSV-2 when index values are low. In these cases, confirmatory testing and careful interpretation are essential. The CDC recommends these tests for individuals with unclear symptoms or those who may have been exposed but haven’t developed visible sores.
Swabs Only Useful During Active Outbreaks
When lesions are present, a swab test—preferably a PCR—is the gold standard for diagnosis. Swabs should ideally be taken within the first 48 hours of symptom onset, before sores begin to scab. PCR testing is now preferred over viral culture because of its higher sensitivity, especially in early-stage lesions.
Timing matters: once a sore starts to heal or crust over, the likelihood of detecting the virus drops significantly. A delayed or improperly collected sample can lead to false negatives, even in someone who has herpes.
Infection Site Doesn’t Always Match the Virus Type
Although HSV-1 is commonly found orally and HSV-2 genitally, this isn’t a hard rule. HSV-1 can cause genital infections, and HSV-2, though rarely, can appear orally. This overlap makes it important not to assume the site of infection based solely on the virus type.
To reach an accurate diagnosis, clinicians often combine lab results with a detailed patient history. Information about prior symptoms, sexual activity, and outbreak patterns can help pinpoint the type and location of infection. Even in the absence of current symptoms, this contextual insight is key to managing the condition effectively and helping individuals understand their risks and options.
Why the Distinction Matters (and When It Doesn’t)
Knowing whether an infection is caused by HSV-1 or HSV-2—and where it’s located—can influence how someone navigates treatment, communication, and risk. But it’s also important to remember that both types are manageable, and neither defines a person’s worth or health.
Impacts Treatment Plans, Disclosure Conversations, and Risk Discussions
The type of herpes a person has can guide treatment decisions. HSV-2, especially when it causes genital outbreaks, tends to recur more often than HSV-1. For that reason, people with genital HSV-2 are more likely to benefit from daily suppressive therapy, which helps reduce the frequency of outbreaks and lowers the risk of transmission. In contrast, someone with infrequent oral HSV-1 outbreaks might choose to treat symptoms only when they arise.
Type also matters when it comes to disclosure. While both types can be stigmatized, genital HSV—most often caused by HSV-2—carries a heavier emotional burden. Fear of judgment or rejection can make it difficult for people to talk openly with partners, even though open communication is key to safer sex and mutual understanding. Many individuals report that the social and emotional consequences of herpes feel more challenging than the physical symptoms.
But Ultimately, Both Types Are Manageable
Regardless of the type, herpes is a manageable condition. Antiviral medications such as acyclovir, valacyclovir, and famciclovir help reduce outbreaks, speed healing, and decrease the chance of passing the virus to others. Most people with herpes live healthy, fulfilling lives.
Psychological reactions can be intense at first, but they often ease with time, information, and support. Education and counseling not only improve how people manage the virus but also strengthen their emotional well-being. With good information and care, people with HSV can maintain strong relationships and a high quality of life.
Emphasis on Whole-Person Health and Stigma Reduction
Stigma remains one of the biggest barriers to seeking care and disclosing status. It can lead to shame, isolation, and delays in diagnosis or treatment. But this doesn’t have to be the case.
Reframing herpes as a common and manageable health issue—rather than a moral failing—creates space for empathy and understanding. Healthcare providers play a vital role in setting this tone. When stigma is addressed directly through clear communication and nonjudgmental care, it empowers individuals to take control of their sexual and emotional health.
Open dialogue also helps normalize the condition, encouraging people to talk with partners, friends, or clinicians without fear. The more informed and compassionate our conversations, the more we can shift public perception—and support those living with HSV in every aspect of their lives.
Understanding Herpes Means Reclaiming Confidence
When it comes to herpes, a little clarity goes a long way. Whether it’s HSV-1 or HSV-2, oral or genital, knowing what each type means—and what it doesn’t—can change the conversation from one of confusion and fear to one of informed care and empowerment.
Understanding the differences in transmission, symptoms, recurrence, and emotional impact can help you manage the condition with more confidence and less worry. It also opens the door to better communication with partners, more effective treatment choices, and less power handed over to stigma.
The truth is, herpes is incredibly common and entirely manageable. With the right support and information, it doesn’t have to define your relationships, your health, or how you see yourself. You are more than a diagnosis, and you deserve compassion, both from others and from yourself.
If you found this article helpful, consider joining our mailing list. You’ll get thoughtful updates, fresh resources, and expert-backed content delivered straight to your inbox—because you deserve to feel informed, supported, and in control of your health.
References
Arvin, A., & Prober, C. (1992). Herpes simplex virus infections: the genital tract and the newborn. Pediatrics in Review, 13(3), 107–112.
Bartlett, J. (2004). Recent developments in the management of herpes simplex virus infection in HIV-infected persons. Clinical Infectious Diseases, 39(Suppl 5), S237-S239.
Bobrow, M. (2016). Full Disclosure: Herpes Stigma and Communication Practices among HSV+ Individuals.
Casto, A. M., Huang, M. L., Xie, H., Jerome, K. R., Wald, A., Johnston, C. M., & Greninger, A. L. (2020). Herpes Simplex Virus Mistyping due to HSV-1 × HSV-2 Interspecies Recombination. Viruses, 12(8), 860.
Caulfield, P., & Willis, D. (2015). To disclose or not to disclose: The role of clinicians in advising patients about HSV disclosure. Sexually Transmitted Infections, 91, A34.
Centers for Disease Control and Prevention. (2023). Genital Herpes – CDC Fact Sheet (Detailed).
Chayavichitsilp, P., Buckwalter, J. V., Krakowski, A., & Friedlander, S. (2009). Herpes simplex. Pediatrics in Review, 30(4), 119-129.
Chiuppesi, F., Vannucci, L., de Luca, A., Lai, M., Matteoli, B., Freer, G., et al. (2012). A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections. Journal of Virology, 86(12), 6563–6574.
Corey, L., Wald, A., Patel, R., Sacks, S. L., Tyring, S., Warren, T., … & Study Group. (2004). Once-daily valacyclovir to reduce the risk of transmission of genital herpes. New England Journal of Medicine, 350(1), 11–20.
Daniels, D., & Mortlock, S. (2008). Mixed HSV-1 and HSV-2 infection in a patient attending a GUM clinic. British Journal of Biomedical Science, 65, 203-204.
Fatahzadeh, M., & Schwartz, R. (2007). Human herpes simplex virus infections: Epidemiology, pathogenesis, symptomatology, diagnosis, and management. Journal of the American Academy of Dermatology, 57(5), 737-763.
Gilbert, S. (2006). Oral shedding of herpes simplex virus type 1 in immunocompetent persons. Journal of Oral Pathology & Medicine, 35(9), 548–553.
Johnston, C., Koelle, D. M., & Wald, A. (2011). HSV-2: in pursuit of a vaccine. The Journal of clinical investigation, 121(12), 4600–4609. X
Kimberlin, D. (2006). Herpes simplex virus. Obstetrics and Gynecology Clinics of North America.
Lafferty, W., Coombs, R., Benedetti, J., Critchlow, C., & Corey, L. (1987). Recurrences after oral and genital herpes simplex virus infection: Influence of site of infection and viral type. The New England Journal of Medicine, 316(23), 1444-1449.
Langenberg, A., Burke, R., Adair, S., Sekulovich, R., Tigges, M., Dekker, C., & Corey, L. (1995). A recombinant glycoprotein vaccine for herpes simplex type 2: Safety and efficacy. Annals of Internal Medicine, 122(12), 889–898.
Lee, S., Ives, A. M., & Bertke, A. S. (2015). Herpes Simplex Virus 1 Reactivates from Autonomic Ciliary Ganglia Independently from Sensory Trigeminal Ganglia To Cause Recurrent Ocular Disease. Journal of virology, 89(16), 8383–8391.
Looker, K. J., Magaret, A. S., Turner, K. M., Vickerman, P., Gottlieb, S. L., & Newman, L. M. (2015). Global estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One, 10(5), e0129883.
Mark, K. E., Wald, A., Magaret, A. S., Selke, S., Olin, L., Huang, M. L., & Corey, L. (2008). Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults. The Journal of infectious diseases, 198(8), 1141–1149.
Martin, E. T., Krantz, E., Gottlieb, S. L., Magaret, A. S., Langenberg, A., Stanberry, L., Kamb, M., & Wald, A. (2009). A pooled analysis of the effect of condoms in preventing HSV-2 acquisition. Archives of internal medicine, 169(13), 1233–1240.
Matheu, M. M., Gleason, L., Sun, T., Castro-Pena, N. A., Spears, C., Smith, C., Flores, J., & Taylor, B. (2018). The impact of disclosure stigma on virologic outcomes in people living with HIV. Open Forum Infectious Diseases, 5(Suppl 1), S210–S211.
McQuillan, G., Kruszon-Moran, D., Flagg, E. W., & Paulose-Ram, R. (2018). Prevalence of herpes simplex virus type 1 and type 2 in persons aged 14–49: United States, 2015–2016. National Health Statistics Reports, 112, 1-8.
Meyer, J. L., Crosby, R., Whittington, W., Carrell, D., Ashley-Morrow, R., Meier, A., Harrington, R., DiClemente, R., & Wald, A. (2005). The psychosocial impact of serological herpes simplex type 2 testing in an urban HIV clinic. Sexually Transmitted Infections, 81(4), 309–315.
Miller, R., Whittington, W., Coleman, R., & Nigida, S. (1987). Acquisition of concomitant oral and genital infection with herpes simplex virus type 2. Sexually Transmitted Diseases, 14(1), 41–43.
Nicum, S., & Mahida, N. (2010). The Presentation and Management of Genital Herpes. InnovAiT, 3, 124–127.
Onu, D. U. (2021). Treatment adherence mediates the relationship between HIV-related stigma and health-related quality of life. AIDS Care, 33(10), 1335–1339.
Pero, M., & Espinós, J. J. (2016). Genital Herpes Simplex Virus Type 1: Case report of oro-genital infection by autotransmission.
Pincock, S. (2006). Herpes increases because oral sex thought safe. BMJ, 333(7567), 516.
Ramchandani, M., Kong, M., Tronstein, E., Selke, S., Mikhaylova, A., Magaret, A., Huang, M. L., Johnston, C., Corey, L., & Wald, A. (2016). Herpes simplex virus type 1 shedding in tears and nasal and oral mucosa of healthy adults. Sexually Transmitted Diseases, 43(12), 756–760.
Rathbun, M. M., Shipley, M. M., Bowen, C. D., et al. (2022). Comparison of herpes simplex virus 1 genomic diversity between adult sexual transmission partners with genital infection. PLoS Pathogens, 18.
Roberts, R. E., & Marcos, S. (2016). Media Representations of Herpes.
Sasadeusz, J., & Sacks, S. (1994). Herpes latency, meningitis, radiculomyelopathy and disseminated infection. Genitourinary Medicine, 70, 369–377.
Scott, E., & Burkhart, C. (2024). Herpes Simplex Virus: An Immunopathological Review. JAAD Reviews.
Shearer, L., Simmons, L., Mindel, A., Stanberry, L., & Rosenthal, S. (2011). Reducing the stigma of HSV through brief publicly-generated videos. Sexually Transmitted Infections, 87, A259.
Shearer, L., Simmons, L., Mindel, A., Stanberry, L., & Rosenthal, S. (2012). Reducing the stigma of herpes simplex virus infection: lessons from an online video contest. Sexual Health, 9(5), 438–444.
Taylor, T. J., Brockman, M. A., McNamee, E. E., & Knipe, D. M. (2002). Herpes simplex virus. Frontiers in bioscience : a journal and virtual library, 7, d752–d764.
Thin, R. (1991). Management of Genital Herpes Simplex Infection. International Journal of STD & AIDS, 2(5), 313–317.
Turner, K., McFarland, W., Kellogg, T. A., Wong, E., Page-Shafer, K., Louie, B., et al. (2003). Incidence and prevalence of herpes simplex virus type 2 infection in persons seeking repeat HIV counseling and testing. Sexually Transmitted Diseases, 30(4), 331–334.
Usatine, R.P., & Tinitigan, R. (2010). Nongenital herpes simplex virus. American family physician, 82 9, 1075-82 .
Wald A. (1998). Herpes. Transmission and viral shedding. Dermatologic clinics, 16(4), 795–xiv.
Wald, A., & Corey, L. (2018). The clinical features and diagnostic evaluation of genital herpes. In L. Stanberry (Ed.), Genital and Neonatal Herpes. Red Book Point-of-Care Clinical Decision Support Tool.
Wald, A., Langenberg, A., Krantz, E., Douglas, J., Handsfield, H., & Corey, L. (2005). The relationship between condom use and herpes simplex virus acquisition. Annals of Internal Medicine, 143(10), 707–713.
Wald, A., Zeh, J., Barnum, G., Davis, L. G., & Corey, L. (1996). Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Annals of internal medicine, 124(1 Pt 1), 8–15.
Whale, J., Clarke, E., Patel, N., Graham, C., Ingham, R., & Patel, R. (2013). A psychological experiment to examine stigma in response to HSV-1 disclosures. Sexually Transmitted Infections, 89, A39.
Whitley, R. J., & Roizman, B. (2001). Herpes simplex virus infections. Lancet (London, England), 357(9267), 1513–1518.
Wilson, M., & Wilson, P. J. K. (2021). Genital Herpes. Close Encounters of the Microbial Kind.
Workowski, K. A., & Bachmann, L. H. (2021). Sexually transmitted infections treatment guidelines, 2021. MMWR Recommendations and Reports, 70(4), 1–187.
Workowski, K. A., Bolan, G. A., & Centers for Disease Control and Prevention (2015). Sexually transmitted diseases treatment guidelines, 2015. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 64(RR-03), 1–137.
Young, H., & Ogilvie, M. (1994). Herpes simplex virus (HSV-1; HSV-2) (Genital herpes). In Sexually Transmitted Infections (pp. 184–238).
Yunita, I., Hidayati, A., Widyantari, S., et al. (2024). Exploring the complex interplay of herpes simplex virus and HIV/AIDS – a comprehensive narrative review. Bali Medical Journal.
